# Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI)

> **NCT01338909** · PHASE3 · COMPLETED · sponsor: **University of Patras** · enrollment: 35 (estimated)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Prasugrel
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01338909
- **Lead sponsor:** University of Patras
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2011-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01338909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01338909, "Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01338909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*